Target
Kallikrein-14
Ligand
BDBM51911
Substrate
n/a
Meas. Tech.
ChEMBL_973067 (CHEMBL2412648)
IC50
970±n/a nM
Citation
 Tan, XFurio, LReboud-Ravaux, MVilloutreix, BOHovnanian, AEl Amri, C 1,2,4-Triazole derivatives as transient inactivators of kallikreins involved in skin diseases. Bioorg Med Chem Lett 23:4547-51 (2013) [PubMed]  Article 
Target
Name:
Kallikrein-14
Synonyms:
KLK-L6 | KLK14 | KLK14_HUMAN | KLKL6 | Kallikrein 14 | Kallikrein-14 | Kallikrein-like protein 6 | hK14
Type:
PROTEIN
Mol. Mass.:
29136.99
Organism:
Homo sapiens (Human)
Description:
ChEMBL_1282452
Residue:
267
Sequence:
MSLRVLGSGTWPSAPKMFLLLTALQVLAIAMTQSQEDENKIIGGHTCTRSSQPWQAALLAGPRRRFLCGGALLSGQWVITAAHCGRPILQVALGKHNLRRWEATQQVLRVVRQVTHPNYNSRTHDNDLMLLQLQQPARIGRAVRPIEVTQACASPGTSCRVSGWGTISSPIARYPASLQCVNINISPDEVCQKAYPRTITPGMVCAGVPQGGKDSCQGDSGGPLVCRGQLQGLVSWGMERCALPGYPGVYTNLCKYRSWIEETMRDK
  
Inhibitor
Name:
BDBM51911
Synonyms:
(4-isopropoxybenzyl)-[3-(2-methoxyphenyl)-3-(4-methoxyphenyl)propyl]amine | 3-(2-methoxyphenyl)-3-(4-methoxyphenyl)-N-[(4-propan-2-yloxyphenyl)methyl]-1-propanamine | 3-(2-methoxyphenyl)-3-(4-methoxyphenyl)-N-[(4-propan-2-yloxyphenyl)methyl]propan-1-amine | MLS001164329 | SMR000539687 | cid_3730081
Type:
Small organic molecule
Emp. Form.:
C27H33NO3
Mol. Mass.:
419.5558
SMILES:
COc1ccc(cc1)C(CCNCc1ccc(OC(C)C)cc1)c1ccccc1OC
Structure:
Search PDB for entries with ligand similarity: